The Study of Atherosclerosis With Ramipril and Rosiglitazone

Clinical trial NCT00140647 · COMPLETED

Trial details

NCT number: NCT00140647
Sponsor: Gerstein, Hertzel, MD
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerosis Impaired Glucose Tolerance Isolated Impaired Fasting Glucose Cardiovascular Disease

Start date: 2001-07-01
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.